UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Antifungal Drug Resistance: Mechanisms, Epidemiology, and Consequences for Treatment

The American journal of medicine, 2012, Vol.125 (1), p.S3-S13

Pfaller, Michael A., MD

2012

Volltextzugriff (PDF)

The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program

Antimicrobial agents and chemotherapy, 2019-07, Vol.63 (7)

2019

Volltextzugriff (PDF)

Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004-2008

PloS one, 2014-07, Vol.9 (7), p.e101510-e101510

2014

Volltextzugriff (PDF)

Ceftolozane-Tazobactam Activity against Pseudomonas aeruginosa Clinical Isolates from U.S. Hospitals: Report from the PACTS Antimicrobial Surveillance Program, 2012 to 2015

Antimicrobial agents and chemotherapy, 2017-07, Vol.61 (7)

2017

Volltextzugriff (PDF)

Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance Registry

Clinical infectious diseases, 2009-06, Vol.48 (12), p.1695-1703

2009

Volltextzugriff (PDF)

Differential Activity of the Oral Glucan Synthase Inhibitor SCY-078 against Wild-Type and Echinocandin-Resistant Strains of Candida Species

Antimicrobial agents and chemotherapy, 2017-08, Vol.61 (8)

2017

Volltextzugriff (PDF)

T2MR and T2Candida: novel technology for the rapid diagnosis of candidemia and invasive candidiasis

Future microbiology, 2016-01, Vol.11 (1), p.103-117

2016

Volltextzugriff (PDF)

Candida Bloodstream Infections: Comparison of Species Distributions and Antifungal Resistance Patterns in Community-Onset and Nosocomial Isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009

Antimicrobial Agents and Chemotherapy, 2011-02, Vol.55 (2), p.561-566

2011

Volltextzugriff (PDF)

Surveillance of Omadacycline Activity against Clinical Isolates from a Global Collection (North America, Europe, Latin America, Asia-Western Pacific), 2010-2011

Antimicrobial agents and chemotherapy, 2017-05, Vol.61 (5)

2017

Volltextzugriff (PDF)

Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008–2009)

International journal of antimicrobial agents, 2011-07, Vol.38 (1), p.65-69

2011

Volltextzugriff (PDF)

Azole Resistance in Aspergillus fumigatus Isolates from the ARTEMIS Global Surveillance Study Is Primarily Due to the TR/L98H Mutation in the cyp51A Gene

Antimicrobial Agents and Chemotherapy, 2011-09, Vol.55 (9), p.4465-4468

2011

Volltextzugriff (PDF)

Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program

Antimicrobial agents and chemotherapy, 2017-03, Vol.61 (3)

2017

Volltextzugriff (PDF)

In Vitro Activity of a New Oral Glucan Synthase Inhibitor (MK-3118) Tested against Aspergillus spp. by CLSI and EUCAST Broth Microdilution Methods

Antimicrobial Agents and Chemotherapy, 2013-02, Vol.57 (2), p.1065-1068

2013

Volltextzugriff (PDF)

Antifungal susceptibilities of opportunistic filamentous fungal pathogens from the Asia and Western Pacific Region: data from the SENTRY Antifungal Surveillance Program (2011-2019)

Journal of antibiotics, 2021-08, Vol.74 (8), p.519-527

2021

Volltextzugriff (PDF)

Antifungal susceptibilities of Candida, Cryptococcus neoformans and Aspergillus fumigatus from the Asia and Western Pacific region: data from the SENTRY antifungal surveillance program (2010-2012)

Journal of antibiotics, 2015-09, Vol.68 (9), p.556-561

2015

Volltextzugriff (PDF)

Trends in the susceptibility of U.S. Acinetobacter baumannii-calcoaceticus species complex and Stenotrophomonas maltophilia isolates to minocycline, 2014-2021

Microbiology spectrum, 2023-12, Vol.11 (6), p.e0198123-e0198123

2023

Volltextzugriff (PDF)

Frequency of fks Mutations among Candida glabrata Isolates from a 10-Year Global Collection of Bloodstream Infection Isolates

Antimicrobial Agents and Chemotherapy, 2014-01, Vol.58 (1), p.577-580

2014

Volltextzugriff (PDF)

Ceftolozane-tazobactam activity against clinical isolates of Pseudomonas aeruginosa from ICU patients with pneumonia: United States, 2015–2018

International journal of infectious diseases, 2021-11, Vol.112, p.321-326

2021

Volltextzugriff (PDF)

Activities of E1210 and Comparator Agents Tested by CLSI and EUCAST Broth Microdilution Methods against Fusarium and Scedosporium Species Identified Using Molecular Methods

Antimicrobial Agents and Chemotherapy, 2012-01, Vol.56 (1), p.352-357

2012

Volltextzugriff (PDF)

Ceftolozane-tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in Latin America: report from an antimicrobial surveillance program (2013–2015)

The Brazilian journal of infectious diseases, 2017-11, Vol.21 (6), p.627-637

2017

Volltextzugriff (PDF)

Low Prevalence of fks1 Hot Spot 1 Mutations in a Worldwide Collection of Candida Strains

Antimicrobial Agents and Chemotherapy, 2010-06, Vol.54 (6), p.2655-2659

2010

Volltextzugriff (PDF)

Surveillance of omadacycline activity tested against clinical isolates from the USA: report from the SENTRY Antimicrobial Surveillance Program, 2019

Journal of global antimicrobial resistance., 2021-12, Vol.27, p.337-351

2021

Volltextzugriff (PDF)

Has Antifungal Susceptibility Testing Come of Age?

Clinical infectious diseases, 2002-10, Vol.35 (8), p.982-989

2002

Volltextzugriff (PDF)

Caspofungin Etest Susceptibility Testing of Candida Species: Risk of Misclassification of Susceptible Isolates of C. glabrata and C. krusei when Adopting the Revised CLSI Caspofungin Breakpoints

Antimicrobial Agents and Chemotherapy, 2012-07, Vol.56 (7), p.3965-3968

2012

Volltextzugriff (PDF)

Antimicrobial activity of ceftolozane/tazobactam tested against contemporary (2015–2017) Pseudomonas aeruginosa isolates from a global surveillance programme

Journal of global antimicrobial resistance., 2020-06, Vol.21, p.60-64

2020

Volltextzugriff (PDF)

1 – 25 von 420

Suche als RSS-Feed

Aktive Filter

ThemaMycology

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(411)
Mit Volltextzugriff
(358)

Publikationsform

Artikel
(420)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(380)
Life Sciences & Biomedicine
(373)
Humans
(333)
Microbiology
(263)
Biological And Medical Sciences
(234)
Infectious Diseases
(216)
Medical Sciences
(198)
Microbial Sensitivity Tests
(178)
Pharmacology. Drug Treatments
(123)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(118)
Pharmacology & Pharmacy
(98)
Anti-Bacterial Agents - Pharmacology
(97)
Antifungal Agents - Pharmacology
(88)
Male
(73)
Female
(69)
Fundamental And Applied Biological Sciences. Psychology
(62)
Antibacterial Agents
(61)
Infections
(60)
Antifungal Agents
(58)
Drug Resistance, Microbial
(56)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Antifungal Drug Resistance: Mechanisms, Epidemiology, and Consequences for Treatment

The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program

Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004-2008

Ceftolozane-Tazobactam Activity against Pseudomonas aeruginosa Clinical Isolates from U.S. Hospitals: Report from the PACTS Antimicrobial Surveillance Program, 2012 to 2015

Epidemiology and Outcomes of Candidemia in 2019 Patients: Data from the Prospective Antifungal Therapy Alliance Registry

Differential Activity of the Oral Glucan Synthase Inhibitor SCY-078 against Wild-Type and Echinocandin-Resistant Strains of Candida Species

T2MR and T2Candida: novel technology for the rapid diagnosis of candidemia and invasive candidiasis

Candida Bloodstream Infections: Comparison of Species Distributions and Antifungal Resistance Patterns in Community-Onset and Nosocomial Isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009

Surveillance of Omadacycline Activity against Clinical Isolates from a Global Collection (North America, Europe, Latin America, Asia-Western Pacific), 2010-2011

Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008–2009)

Azole Resistance in Aspergillus fumigatus Isolates from the ARTEMIS Global Surveillance Study Is Primarily Due to the TR/L98H Mutation in the cyp51A Gene

Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program

In Vitro Activity of a New Oral Glucan Synthase Inhibitor (MK-3118) Tested against Aspergillus spp. by CLSI and EUCAST Broth Microdilution Methods

Antifungal susceptibilities of opportunistic filamentous fungal pathogens from the Asia and Western Pacific Region: data from the SENTRY Antifungal Surveillance Program (2011-2019)

Antifungal susceptibilities of Candida, Cryptococcus neoformans and Aspergillus fumigatus from the Asia and Western Pacific region: data from the SENTRY antifungal surveillance program (2010-2012)

Trends in the susceptibility of U.S. Acinetobacter baumannii-calcoaceticus species complex and Stenotrophomonas maltophilia isolates to minocycline, 2014-2021

Frequency of fks Mutations among Candida glabrata Isolates from a 10-Year Global Collection of Bloodstream Infection Isolates

Ceftolozane-tazobactam activity against clinical isolates of Pseudomonas aeruginosa from ICU patients with pneumonia: United States, 2015–2018

Activities of E1210 and Comparator Agents Tested by CLSI and EUCAST Broth Microdilution Methods against Fusarium and Scedosporium Species Identified Using Molecular Methods

Ceftolozane-tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in Latin America: report from an antimicrobial surveillance program (2013–2015)

Low Prevalence of fks1 Hot Spot 1 Mutations in a Worldwide Collection of Candida Strains

Surveillance of omadacycline activity tested against clinical isolates from the USA: report from the SENTRY Antimicrobial Surveillance Program, 2019

Has Antifungal Susceptibility Testing Come of Age?

Caspofungin Etest Susceptibility Testing of Candida Species: Risk of Misclassification of Susceptible Isolates of C. glabrata and C. krusei when Adopting the Revised CLSI Caspofungin Breakpoints

Antimicrobial activity of ceftolozane/tazobactam tested against contemporary (2015–2017) Pseudomonas aeruginosa isolates from a global surveillance programme

Aktive Filter

Suchergebnisse filtern